Deflazacort versus 6-methylprednisolone in renal transplantation: immunosuppressive activity and side effects.
Elli
A
A
Istituto di Clinica Medica Ia, Università di Milano, Italy.
Rivolta
R
R
Palazzi
P
P
Mascaretti
L
L
Puglisi
G
G
Parenti
M
M
Sioli
V
V
Di Palo
F Q
FQ
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D002986:Clinical Trials as Topic; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008775:Methylprednisolone / Q000009:adverse effects / Q000627:therapeutic use*; D011282:Pregnenediones / Q000009:adverse effects / Q000627:therapeutic use*; D011897:Random Allocation
D000893:Anti-Inflammatory Agents; D001786:Blood Glucose; D008076:Cholesterol, HDL; D007166:Immunosuppressive Agents; D011282:Pregnenediones; D002784:Cholesterol; C021988:deflazacort; D008775:Methylprednisolone